News

Jubilant Pharmova announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 5 per equity Share (i.e. 500%) , subject to the approval of the shareholders.

Net profit of Jubilant Pharmova declined 22.27% to Rs 119.40 crore in the quarter ended March 2026 as against Rs 153.60 crore during the previous quarter ended March 2025. Sales rose 18.60% to Rs 2272.20 crore in the quarter ended March 2026 as against Rs 1915.80 crore during the previous quarter ended March 2025.For the full year,net profit declined 52.53% to Rs 398.50 crore in the year ended March 2026 as against Rs 839.40 crore during the previous year ended March 2025. Sales rose 14.36% to Rs 8225.00 crore in the year ended March 2026 as against Rs 7192.10 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2272.201915.80 19 8225.007192.10 14 OPM %14.9318.02 -15.3116.31 - PBDT306.50304.50 1 1113.70989.70 13 PBT189.70209.30 -9 673.30621.10 8 NP119.40153.60 -22 398.50839.40 -53 Powered by Capital Market - Live News

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Net profit of Jubilant Pharmova declined 44.60% to Rs 55.90 crore in the quarter ended December 2025 as against Rs 100.90 crore during the previous quarter ended December 2024. Sales rose 16.67% to Rs 2116.10 crore in the quarter ended December 2025 as against Rs 1813.70 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2116.101813.70 17 OPM %13.6815.83 - PBDT253.80240.70 5 PBT133.10149.40 -11 NP55.90100.90 -45 Powered by Capital Market - Live News

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News